We help keep Philadelphia healthy by averting vaccine-preventable diseases and increasing immunization coverage across the city.
The programs we run empower clinics to provide vaccines for individuals who would otherwise not have access to them.
Learn how to order vaccine, track your order, and manage your inventory through PhilaVax.
Contact & resources
Keep Philadelphia healthy by removing the financial barriers to immunization for patients.
Learn about what to do in the event of a temperature excursion and how to get back on track.
Contact & resources
The Philadelphia Immunization Program thanks you for participating in the COVID-19 Bridge Access Program.
Now that the Bridge Access Program has ended, we’re asking providers who were enrolled to share their experiences and help us improve.
Digital Data Loggers (DDLs) provided by the Philadelphia Department of Public Health (PDPH) use LogTag software to download temperature data.
LogTag version 2 is no longer supported and may cause data reporting errors.
All providers who use PDPH-provided DDLs must update their software to LogTag version 3.
Reach out to TempCheck@phila.gov with any questions.
Register now! Join us for the Philadelphia Immunization Coalition (PIC) adult-focused conference.
Speakers include:
Quick links:
This conference is open to all healthcare professionals.
$30
June 03, 2025
8:00 a.m. – 3:30 p.m.
College of Physicians at 19 South 22nd Street, Philadelphia, PA 19103
Join us for an informative virtual session on respiratory viruses.
This session is for primary care physicians (PCPs) and other vaccine providers to learn more about:
Infectious disease expert Dr. Mayssa Abuali will give an overview of respiratory viral epidemiology and provide related immunization updates, and the VFC team will provide programmatic updates.
Tuesday, September 9, 2025
12:00 p.m. – 1:00 p.m.
Protect your patients against respiratory diseases by ordering free, educational print materials for your office! These materials are designed to facilitate informed conversations about immunizations and help tailor discussions to patients’ individual circumstances. Need support when discussing the importance and safety of vaccines? We also...
The Vaccines for Adults at Risk (VFAAR) program’s FluLaval supply has run out for the season. Pediatric influenza vaccine doses are still available through the Vaccines for Children (VFC) program for VFC-eligible patients. Please do not submit any new orders for adult influenza vaccine, as these requests will be rejected....
The vaccine distribution center will have reduced delivery capacity during the holiday season. Orders submitted during this time will take longer than usual to ship. November: December: January: Ordering Tips: For assistance with completing your reconciliation or submitting your order, email our team at DPHProviderhelp@phila.gov.
On September 18-19, 2025, CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend: Clinical Background: MMRV Vaccine The MMRV vaccine is a combination vaccine against measles, mumps, rubella, and varicella. The ACIP made this decision on the basis that the MMRV vaccine is linked...
VFC providers can now order Moderna, Pfizer, & Sanofi 2025-2026 COVID-19 products for their eligible patients.Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products. These are the vaccines available this year: *Pfizer 6 mos – 4 years is no longer available.**This...
On February 14, 2025, the Food and Drug Administration (FDA) approved GSK’s MenABCWY vaccine, Penmenvy, for use in individuals aged 10 through 25 years. Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is now available through the Vaccines for Children (VFC) program. The vaccine...
On June 9, 2025, the Food and Drug Administration (FDA) licensed Merck’s Enflonsia (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI). On June 26, 2025, the Advisory Committee on Immunization Practices(ACIP) voted to recommend clesrovimab for use in infants younger...
Vaccines for Children (VFC) providers are now welcome to order nirsevimab (Beyfortus) as needed. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025 to March 31, 2026. Once we receive your nirsevimab...
Provider? Stay in the know:
Get the newest information from the Immunization Program right in your inbox!